2 Cash-Producing Stocks to Target This Week and 1 We Ignore [Yahoo! Finance]
Repligen Corporation (RGEN)
Last repligen corporation earnings: 2/20 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
repligen.com/investors
Company Research
Source: Yahoo! Finance
Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning. Luckily for you, we built StockStory to help you separate the good from the bad. That said, here are two cash-producing companies that leverage their financial strength to beat the competition and one best left off your watchlist. Trailing 12-Month Free Cash Flow Margin: 15.5% With over 13 strategic acquisitions since 2012 to build its comprehensive bioprocessing portfolio, Repligen (NASDAQ:RGEN) develops and manufactures specialized technologies that improve the efficiency and flexibility of biological drug manufacturing processes. Why Should You Dump RGEN? Absence of organic revenue growth over the past two years suggests it may have to lean into acquisitions to drive its expansion Costs have risen faster than its revenue over the last five years, causing its adjusted operating margin to decline by 17.8 percentage points Waning returns on capital from an alre
Show less
Read more
Impact Snapshot
Event Time:
RGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGEN alerts
High impacting Repligen Corporation news events
Weekly update
A roundup of the hottest topics
RGEN
News
- UBS Tags Repligen (RGEN) as Bioprocessing Leader for 2026, Cites 20% Order Growth and Reshoring Tailwinds [Yahoo! Finance]Yahoo! Finance
- ???????????????????????2026:??????????????? [CNET News]CNET News
- Conestoga SMid Cap Composite Q4 2025 Commentary [Seeking Alpha]Seeking Alpha
- Is It Too Late To Consider Buying Repligen Corporation (NASDAQ:RGEN)? [Yahoo! Finance]Yahoo! Finance
- Repligen (NASDAQ:RGEN) had its "buy" rating reaffirmed by analysts at UBS Group AG.MarketBeat
RGEN
Earnings
- 10/28/25 - Beat
RGEN
Sec Filings
- 1/12/26 - Form 4
- 1/12/26 - Form 3
- 1/6/26 - Form 8-K
- RGEN's page on the SEC website